Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies
Clicks: 127
ID: 268121
2018
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.6
/100
2 views
2 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Protease inhibitor (PI) monotherapy is a potential approach to alleviate antiretroviral treatment. We pooled the results of 3 PI/r monotherapy trials and demons| Reference Key |
sidonie2018clinicalultrasensitive
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lambert-Niclot, Sidonie;Grude, Maxime;Meynard, Jean-Luc;Marcelin, Anne-Geneviève;Valantin, Marc-Antoine;Flandre, Philippe;Izopet, Jacques;Moinot, Laetitia;Bouteloup, Vincent;Calvez, Vincent;Katlama, Christine;Girard, Pierre-Marie;Morand-Joubert, Laurence; |
| Journal | clinical infectious diseases |
| Year | 2018 |
| DOI | DOI not found |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.